BD, Biocorp sign agreement to bring connectivity, traceability to self-administered injectable drugs
FRANKLIN LAKES, N.J. — BD (Becton, Dickinson and Company) and Biocorp, a medical device and delivery systems manufacturer based in France, announced Tuesday that they have signed an agreement with the aim of using connected technology to track adherence for self-administered drug therapies, like biologics. To support biopharmaceutical companies in their efforts to improve the adherence
